PathAI builds AI-powered pathology software and diagnostic services for biopharma, pathology labs, and health systems to support disease detection, clinical trials, and companion diagnostics. Offerings include machine-learning models for digital histopathology and a CLIA-certified lab operation. Founded in 2016 and headquartered in Boston, it operates as part of Quest Diagnostics and focuses heavily on oncology and immunology applications.